We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
- Authors
Greene, Sharon K; Li, Lingling; Shay, David K; Fry, Alicia M; Lee, Grace M; Jacobsen, Steven J; Baxter, Roger; Irving, Stephanie A; Jackson, Michael L; Naleway, Allison L; Nordin, James D; Narwaney, Komal J; Lieu, Tracy A
- Abstract
An association between the influenza antiviral medication oseltamivir and neuropsychiatric events has been suggested by post-marketing case reports in Japan. This possible association was not supported by cohort studies in the U.S. conducted prior to the 2009 influenza A (H1N1) pandemic, when usage rates were comparatively low. We assessed oseltamivir safety before and during the pandemic using biologically plausible risk intervals, particularly focusing on psychiatric events.
- Publication
Pharmacoepidemiology and drug safety, 2013, Vol 22, Issue 4, p335
- ISSN
1099-1557
- Publication type
Journal Article
- DOI
10.1002/pds.3363